Davutamig, CAS 2648058-48-2

Product Description: Davutamig (REGN-5093) is a human immunoglobulin G4-kappa, anti-MET monoclonal antibody targeting two different nonoverlapping epitopes on MET. Davutamig is an antineoplastic[1].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 36, No. 4, 2022.

CAS Number: 2648058-48-2

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: c-Met/HGFR

• SKU: MEXHY-P990073-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P990073-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated